title: Cyclosporine-induced hemolytic uremic syndrome: factors that obscure its diagnosis.
authors.affiliation: Kidney Transplant Program, UCLA School of Medicine.
authors.forename: S
authors.initials: S
authors.lastname: Katznelson
authors.forename: A
authors.initials: A
authors.lastname: Wilkinson
authors.forename: T R
authors.initials: TR
authors.lastname: Rosenthal
authors.forename: A
authors.initials: A
authors.lastname: Cohen
authors.forename: C
authors.initials: C
authors.lastname: Nast
authors.forename: G M
authors.initials: GM
authors.lastname: Danovitch
mesh_terms: D000328:Adult; D016572:Cyclosporine / Q000009:adverse effects*; D003937:Diagnosis, Differential; D005260:Female; D006463:Hemolytic-Uremic Syndrome / Q000139:chemically induced* / Q000175:diagnosis* / Q000628:therapy; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
chemical_list: D016572:Cyclosporine